Literature DB >> 19331578

Vaginal colonization by probiotic Lactobacillus crispatus CTV-05 is decreased by sexual activity and endogenous Lactobacilli.

May A D Antonio1, Leslie A Meyn, Pamela J Murray, Barbara Busse, Sharon L Hillier.   

Abstract

BACKGROUND: Two potencies of gelatin capsules containing Lactobacillus crispatus CTV-05 were evaluated for safety and vaginal colonization in 90 young women.
METHODS: Sexually active females aged 14-21 years were randomized to receive either 10(6)- or 10(8)-cfu CTV-05 capsules inserted intravaginally twice daily for 3 days. At enrollment and at 4 weekly follow-up visits, behavioral and demographic information and quantitative vaginal cultures were collected. Lactobacillus species were identified by DNA hybridization, and the CTV-05 strain was discerned using repetitive-sequence polymerase chain reaction DNA fingerprinting.
RESULTS: Of the 90 participants, 87 returned for at least 2 follow-up visits. Of 40 participants who lacked L. crispatus colonization at enrollment, 36 (90%) were successfully colonized by CTV-05 at 1 or more follow-up visits, whereas only 24 (51%) of 47 participants colonized by L. crispatus at enrollment were positive for CTV-05 at follow-up (P < .001). Compared with sexually abstinent participants, females engaging in sexual intercourse with the use of condoms (odds ratio [OR], 6.3 [95% confidence interval {CI}, 1.3-29.4]; P = .02) or having unprotected sex (OR, 75.5 [95% CI, 6.9-820.6]; P < .001) during the first week were less likely to become colonized by CTV-05.
CONCLUSIONS: These data suggest that the factors that predict failure to become colonized by probiotic lactobacilli include exposure to semen, vaginal intercourse, and the presence of lactobacilli of the same species at enrollment.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19331578     DOI: 10.1086/598686

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  38 in total

1.  Responders and non-responders to probiotic interventions: how can we improve the odds?

Authors:  Gregor Reid; Estelle Gaudier; Francisco Guarner; Gary B Huffnagle; Jean M Macklaim; Alicia M Munoz; Margaret Martini; Tamar Ringel-Kulka; Balfour Sartor; Robert Unal; Kristin Verbeke; Jens Walter
Journal:  Gut Microbes       Date:  2010 May-Jun

Review 2.  Exploring a road map to counter misconceptions about the cervicovaginal microbiome and disease.

Authors:  Jean M Macklaim; Craig R Cohen; Gilbert Donders; Gregory B Gloor; Janet E Hill; Groesbeck P Parham; Jacques Ravel; Gregory Spear; Janneke van de Wijgert; Gregor Reid
Journal:  Reprod Sci       Date:  2012-05-21       Impact factor: 3.060

3.  Sexually transmitted diseases treatment guidelines, 2015.

Authors:  Kimberly A Workowski; Gail A Bolan
Journal:  MMWR Recomm Rep       Date:  2015-06-05

4.  At the crossroads of vaginal health and disease, the genome sequence of Lactobacillus iners AB-1.

Authors:  Jean M Macklaim; Gregory B Gloor; Kingsley C Anukam; Sarah Cribby; Gregor Reid
Journal:  Proc Natl Acad Sci U S A       Date:  2010-11-08       Impact factor: 11.205

5.  Randomized Trial of Lactin-V to Prevent Recurrence of Bacterial Vaginosis.

Authors:  Craig R Cohen; Michael R Wierzbicki; Audrey L French; Sheldon Morris; Sara Newmann; Hilary Reno; Lauri Green; Steve Miller; Jonathan Powell; Thomas Parks; Anke Hemmerling
Journal:  N Engl J Med       Date:  2020-05-14       Impact factor: 91.245

6.  Probiotics: the potential for a live microbicide to prevent HIV.

Authors:  Anke Hemmerling; Craig R Cohen
Journal:  J Acquir Immune Defic Syndr       Date:  2011-03-01       Impact factor: 3.731

7.  Effect of sexual activity on vaginal colonization with hydrogen peroxide-producing lactobacilli and Gardnerella vaginalis.

Authors:  Caroline Mitchell; Lisa E Manhart; Katherine K Thomas; Kathy Agnew; Jeanne M Marrazzo
Journal:  Sex Transm Dis       Date:  2011-12       Impact factor: 2.830

Review 8.  The vaginal microbiome: new information about genital tract flora using molecular based techniques.

Authors:  R F Lamont; J D Sobel; R A Akins; S S Hassan; T Chaiworapongsa; J P Kusanovic; R Romero
Journal:  BJOG       Date:  2011-01-20       Impact factor: 6.531

9.  Distinct Effects of the Cervicovaginal Microbiota and Herpes Simplex Type 2 Infection on Female Genital Tract Immunology.

Authors:  B Shannon; P Gajer; T J Yi; B Ma; M S Humphrys; J Thomas-Pavanel; L Chieza; P Janakiram; M Saunders; W Tharao; S Huibner; K Shahabi; J Ravel; R Kaul
Journal:  J Infect Dis       Date:  2017-05-01       Impact factor: 5.226

10.  The restoration of the vaginal microbiota after treatment for bacterial vaginosis with metronidazole or probiotics.

Authors:  Zongxin Ling; Xia Liu; Weiguang Chen; Yueqiu Luo; Li Yuan; Yaxian Xia; Karen E Nelson; Shaolei Huang; Shaoen Zhang; Yuezhu Wang; Jieli Yuan; Lanjuan Li; Charlie Xiang
Journal:  Microb Ecol       Date:  2012-12-19       Impact factor: 4.552

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.